抗体与药物联合体 (ADC):针对癌症治疗的"智能导弹"
Xiaoyang Yao1, Yingying Lu1, Shuo Shi2
1Department of Clinical Laboratory, Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai 200137, China.
Colloids and surfaces. B, Biointerfaces
|September 28, 2025
概括
抗体与药物联合体 (ADC) 通过将抗体与细胞毒药物联系起来,精确地向癌细胞. 本综述探讨了ADC工程,链接器技术和用于增强癌症治疗的有效负载优化方面的进展.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 生物技术是生物技术.
背景情况:
- 抗体-药物合物 (ADC) 是一种先进的治疗方法,通过链接器将单克隆抗体与细胞毒性有效载荷相结合.
- ADCs利用抗体特异性对瘤细胞进行向传递,最大限度地降低非向毒性.
- 癌细胞内部的内化和有效载荷释放诱导了细胞亡,提供了强大的抗癌机制.
研究的目的:
- 审查抗体工程中的最新创新,以改善抗原结合.
- 检查新型链接器设计,增强药物稳定性和释放动力学.
- 探索有效载荷优化策略,以提高抗瘤疗效.
主要方法:
- 关于ADC技术近期进展的综合文献综述.
- 对抗体工程技术,链接器化学和有效载荷开发的分析.
- 综合了关于ADC机制,应用和临床翻译的数据.
主要成果:
- 针对增强瘤细胞识别和结合的抗体设计取得显著进展.
- 开发稳定的链接器,使可控制的有效载荷释放在内部化后.
- 在有效载荷选择和结合中新兴的策略,以获得卓越的抗癌活性.
结论:
- ADCs代表着一个快速发展的向癌症疗法的类别.
- 对抗体,链接器和有效载荷组件的持续创新对于提高ADC有效性至关重要.
- 进一步的研究和临床转化对于充分实现ADC在瘤学中的潜力至关重要.
相关概念视频
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
02:50Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
01:26Targets for Drug Action: Overview
9.9K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
9.9K